Kristen R Ibanez (Kristen Ibanez)

Publication Activity (10 Years)

Years Active: 2024-2024
Publications (10 Years): 5

Top Topics

Combination Therapy

Prognostic Factors

Dna Damage Response

Top Venues

Nature communications

This page only lists publications with an associated author ORCID identifier.

Publications

Kristen R Ibanez, Tzu-Ting Huang, Jung-Min Lee
Combination Therapy Approach to Overcome the Resistance to PI3K Pathway Inhibitors in Gynecological Cancers. Cells 13 (12) (2024)
Kristen R Ibanez, Tzu-Ting Huang, Jung-Min Lee
Combination Therapy Approach to Overcome the Resistance to PI3K Pathway Inhibitors in Gynecological Cancers. Cells 13 (12) (2024)
Elena Giudice, Tzu-Ting Huang, Jayakumar R Nair, Grant Zurcher, Ann McCoy, Darryl Nousome, Marc R Radke, Elizabeth M Swisher, Stanley Lipkowitz, Kristen R Ibanez, Duncan Donohue, Tyler Malys, Min-Jung Lee, Bernadette Redd, Elliot Levy, Shraddha Rastogi, Nahoko Sato, Jane B Trepel, Jung-Min Lee
The CHK1 inhibitor prexasertib in BRCA wild-type platinum-resistant recurrent high-grade serous ovarian carcinoma: a phase 2 trial. Nature communications 15 (1) (2024)
Elena Giudice, Tzu-Ting Huang, Jayakumar R Nair, Grant Zurcher, Ann McCoy, Darryl Nousome, Marc R Radke, Elizabeth M Swisher, Stanley Lipkowitz, Kristen R Ibanez, Duncan Donohue, Tyler Malys, Min-Jung Lee, Bernadette Redd, Elliot Levy, Shraddha Rastogi, Nahoko Sato, Jane B Trepel, Jung-Min Lee
The CHK1 inhibitor prexasertib in BRCA wild-type platinum-resistant recurrent high-grade serous ovarian carcinoma: a phase 2 trial. Nature communications 15 (1) (2024)
Elena Giudice, Tzu-Ting Huang, Jayakumar R Nair, Grant Zurcher, Ann McCoy, Darryl Nousome, Marc R Radke, Elizabeth M Swisher, Stanley Lipkowitz, Kristen R Ibanez, Duncan Donohue, Tyler Malys, Min-Jung Lee, Bernadette Redd, Elliot Levy, Shraddha Rastogi, Nahoko Sato, Jane B Trepel, Jung-Min Lee
The CHK1 inhibitor prexasertib in BRCA wild-type platinum-resistant recurrent high-grade serous ovarian carcinoma: a phase 2 trial. Nature communications 15 (1) (2024)